4//SEC Filing
Meyers Michael L. 4
Accession 0001562180-20-001236
CIK 0001395937other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:36 PM ET
Size
5.5 KB
Accession
0001562180-20-001236
Insider Transaction Report
Form 4
Meyers Michael L.
SVP, Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-12+50,825→ 50,825 totalExercise: $9.47Exp: 2030-02-12→ Common Stock (50,825 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option shall vest monthly over a four-year period.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001664204
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:36 PM ET
- Size
- 5.5 KB